insights_auto
Why is AKBA down 4,78%?
Dive Deeperchevron_right
AKBA:NASDAQ
Akebia Therapeutics Inc
US$0,47
arrow_downward
-4,78%(-0,024) 1D
13 ພ.ຈ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AKBA...
Open
US$0,49
High
US$0,57
Low
US$0,45
Mkt. cap
131,14 ລ້ານ
Avg. vol.
8,79 ລ້ານ
Volume
3,89 ລ້ານ
52-wk high
US$1,84
52-wk low
US$0,36
EPS
US$-0,16
Beta
0,24
Shares outstanding
277,66 ລ້ານ
No. of employees
194
Open
US$0,49
High
US$0,57
Low
US$0,45
Mkt. cap
131,14 ລ້ານ
Avg. vol.
8,79 ລ້ານ
Volume
3,89 ລ້ານ
52-wk high
US$1,84
52-wk low
US$0,36
EPS
US$-0,16
Beta
0,24
Shares outstanding
277,66 ລ້ານ
No. of employees
194
News stories
From web sources and news partners
The Motley Fool
·
24 ນາທີກ່ອນ
Prediction: This Small-Cap Value ETF Will Beat the S&P 500 Over the Next 10 Years
Bloomberg.com
·
1 ຊົ່ວໂມງກ່ອນ
SpaceX’s S&P 500 Bid Gets New Life as Musk Pitches Tesla Merger
Trefis
·
8 ຊົ່ວໂມງກ່ອນ
S&P 500 Movers | Winners: CHTR, STE, GPN | Losers: AMD, DELL, CSCO
Traders Union
·
3 ຊົ່ວໂມງກ່ອນ
Gold volatility surpasses S&P 500 by 2.1 times, Mike McGlone notes
About Akebia Therapeutics Inc
CEO-
Employees194
Founded1 ມ.ກ. 2007
Headquartersແຄມບຣິກ, ມາຊາຊູເຊັດ, ສະຫະລັດ
SectorHealth Care
IndustryBiotechnology
Websiteakebia.com